About Midatech > Intellectual Property
Midatech has IP covering design, manufacture and application/use of nanoparticles in both diagnostic and therapeutic pharmaceutical areas.
Our technology is based on both process and use patents. The initial process for self-assembled nanoparticles was developed at the Consejo Superior de Investigaciones Cientificas (CSIC) in Seville, Spain. Midatech has obtained exclusive world-wide rights from the Spanish Research Council for this technology.
| Patent title | Date | Application number |
|---|---|---|
| Nanoparticles | 16.10.00 | WO/02/32404 A2 |
| Magnetic nanoparticles | 09.06.03 | WO/04/108165 A2 |
| Magnetic nanoparticles of noble metals | 25.03.04 | PCT/ES2005/070035 |
| Nanoparticles comprising RNA ligands | 24.05.04 | WO/05/116226 A2 |
| Nanoparticles comprising antigens and adjuvants and immunogenic structures | 01.10.04 | WO/06/037979 A2 |
| Nanoparticles comprising antibacterial ligands | 04.08.05 | WO/07/015105 |
| Nanoparticles for providing immune responses against infectious agents | 13.04.06 | WO/07/122388 |
| Quantum dots and their uses | 24.04.06 | US-2007-0249064-A1 |
| Dispositivo de hipertermia y su utilizacion con nanoparticulas | 26.07.07 | P200702084 |
| Directed Cancer Therapy using Nanoparticles | 13.11.07 | US60/987519 |